For decades, research has indicated that mifepristone may be a safe and effective contraceptive, but no one has conducted a large clinical trial to produce the evidence required to form the basis for government approval of the drug for this use—until now.
Pioneering reproductive health advocate Dr. Rebecca Gomperts recently announced preliminary results of a large clinical trial in Moldova showing that a 50 mg dose of mifepristone is very effective as a weekly contraceptive pill.